3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia
40
Myelodysplastic Syndromes
38
Leukemia, Myeloid, Acute
34
Lymphoma
31
Leukemia, Lymphocytic, Chronic, B-Cell
31
Lymphoma, Non-Hodgkin
28
Hodgkin Disease
27
Precursor Cell Lymphoblastic Leukemia-Lymphoma
25
Multiple Myeloma
25
Myeloproliferative Disorders
21
Lymphoma, Large B-Cell, Diffuse
21
Lymphoma, Follicular
21
Lymphoma, B-Cell, Marginal Zone
21
Lymphoma, Mantle-Cell
20
Lymphoma, Large-Cell, Immunoblastic
17
Burkitt Lymphoma
17
Primary Myelofibrosis
16
Neoplasms, Plasma Cell
16
Leukemia, Myeloid, Accelerated Phase
16
Congenital Abnormalities
16
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
15
Lymphoma, T-Cell, Cutaneous
14
Leukemia, Myelomonocytic, Chronic
14
Leukemia, Myeloid, Chronic-Phase
14
Graft vs Host Disease
14
Blast Crisis
13
Hematologic Neoplasms
12
Waldenstrom Macroglobulinemia
11
Sezary Syndrome
11
Lymphoma, Extranodal NK-T-Cell
11
Interventions
Amifampridine
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Lambert-Eaton Myasthenic Syndrome
×
Antilymphocyte Serum
×
Clear all
No trials found.